Nuvaxovid is the only protein-based, non-mRNA COVID-19 vaccine available in the United States for the 2025-2026 vaccination ...

In a post on X, HHS Secretary Robert F. Kennedy said the FDA has cleared vaccines from Pfizer, Moderna and Novavax for use in ...

New federal guidelines may limit Covid vaccine access for millions in multiple states. Here are the states affected.

The Food and Drug Administration has approved the 2025-2026 formulation of Nuvaxovid (COVID-19 Vaccine, Adjuvanted).

On August 27, 2025, Novavax announced that the U.S. FDA approved the Nuvaxovid 2025-2026 COVID-19 vaccine formula for adults 65 and older, as well as individuals ages 12-64 with underlying conditions ...

The US Food and Drug Administration approved updated Covid-19 vaccines but for a more limited group: adults age 65 and older ...

New FDA rules limiting eligibility for COVID-19 vaccines have driven up out-of-pocket costs, sparking concern among Baltimore ...

The Food and Drug Administration rescinded the emergency use authorization that made COVID-19 shots available for healthy ...

Parents will still be able to seek out shots from rival drugmaker Moderna, the other maker of mRNA vaccines, which has full ...

The FDA on Wednesday approved the updated COVID-19 vaccines for the 2025-2026 respiratory disease season, but with ...

Novavax slid Thursday in its worst session in more than four months after laying out plans to refinance $225 million of debt, a move that piled onto fresh concerns from a Bank of America downgrade and ...

(CNN) — The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on track to be cleared until Tuesday afternoon, a person familiar ...